Clinical Trials Directory

Trials / Unknown

UnknownNCT02403141

Abu Dhabi Sleep Apnea (ADSA) Study

Status
Unknown
Phase
Study type
Observational
Enrollment
1,400 (estimated)
Sponsor
Imperial College London Diabetes Centre · Academic / Other
Sex
All
Age
18 Years – 64 Years
Healthy volunteers
Accepted

Summary

Obstructive sleep apnoea (OSA) is a common medical problem which, despite increasing awareness, remains under-diagnosed. There is a close association between OSA and obesity; 60-70% of patients diagnosed with OSA are either obese or overweight \[1\]. OSA is also very common among patients with type 2 diabetes. Type 2 Diabetes Mellitus (T2DM) has reached epidemic status in the Gulf region. OSA worsens insulin resistance and leads to weight gain through sleep disturbance \[2\]. Several mechanisms have been proposed for the associations of OSA with diabetes and obesity \[3\]. At present there is little available information regarding the prevalence of OSA in the UAE, the relationship with T2DM and obesity, and the impact of OSA on health outcomes in the Emirati population. This research will explore these relationships and inform public health decisions regarding diagnostic pathways, service provision and treatment protocols.

Conditions

Interventions

TypeNameDescription
OTHERQuestionnaire

Timeline

Start date
2015-03-01
Primary completion
2017-03-01
Completion
2017-03-01
First posted
2015-03-31
Last updated
2017-03-03

Locations

1 site across 1 country: United Arab Emirates

Source: ClinicalTrials.gov record NCT02403141. Inclusion in this directory is not an endorsement.